The 2nd Delhi Orthobiologics Course, hosted under the aegis of the Delhi Orthopaedic Association, concluded recently in the national capital with overwhelming acclaim—cementing its status as one of India’s foremost academic gatherings dedicated to regenerative orthopedics. Held over two intensive days, the course attracted more than 250 delegates and featured over 70 esteemed faculty members from across India and abroad, marking a significant step forward for orthobiologic science in the country.
With a focus on clinical excellence, innovation, and collaborative learning, the event delivered a rich educational experience that blended academic rigor with real-world clinical applications. It was not just a conference—it was a milestone in India’s journey toward integrating cutting-edge biological therapies in musculoskeletal medicine.
A Packed House for Scientific Excellence
Throughout the course, sessions were packed to capacity as delegates engaged enthusiastically with a wide spectrum of topics related to orthobiologic therapies. From platelet-rich plasma (PRP) to bone marrow aspirate concentrate (BMAC), stem cells, and other emerging biologics, the scientific program covered the latest advances and controversies in the field.
Special focus was given to the role of orthobiologics in managing knee and hip arthritis, tendon and ligament injuries, cartilage defects, and complex sports-related pathologies. Presentations were evidence-based, clinically relevant, and reinforced with case discussions, live demonstrations, and expert panels that fostered dynamic exchanges between speakers and attendees.
The course also carried official accreditation with Delhi Medical Council (DMC) credit hours, ensuring that participants not only gained practical insights but also fulfilled their continuing medical education requirements. The structured program, curated by experts with an eye for relevance and innovation, was widely praised for its depth, organization, and educational value.
Vision, Leadership, and Impact
The driving force behind the event’s resounding success was its organizing committee, led by Dr. Karun Jain, who served as the Course Organising Secretary and also holds the post of Joint Secretary of the Delhi Orthopaedic Association. Speaking at the conclusion of the event, Dr. Jain remarked: “The Delhi Orthobiologics Course has successfully ticked all the boxes of what defines a national-level academic event. It was our vision to bring together scientific rigor, clinical applicability, and a collaborative spirit—and we’re proud to say we’ve achieved just that.”
Indeed, the course delivered on its vision—creating a vibrant platform for knowledge-sharing, interdisciplinary dialogue, and future-focused collaboration. Delegates not only left with new knowledge but also with renewed purpose, inspired to take back advanced insights to their clinics, hospitals, and research endeavors.
More Than Just Lectures
While the academic sessions stood at the heart of the course, the event offered much more than lectures. Carefully designed social engagements—including a curated faculty dinner—allowed senior faculty, early-career doctors, and industry experts to build meaningful connections in an informal, collegial setting. This networking aspect proved vital in nurturing future collaborations, mentorships, and interdisciplinary projects.
Delegates were also treated to gourmet dining, comfortable hospitality, and an overall experience that balanced intensive learning with comfort and community. The warmth of Delhi’s medical fraternity was on full display, turning the course into a celebration of knowledge and camaraderie.
Setting the Agenda for the Future: National Consensus on Orthobiologics
Looking beyond the success of the current course, the organizing committee has announced an ambitious and much-needed next step: the development of a National Consensus Statement and India-specific Clinical Protocols for the use of orthobiologics.
This pioneering initiative aims to establish standardized, evidence-backed guidelines that can guide Indian clinicians in the safe, effective, and ethical application of regenerative therapies. With orthobiologics increasingly entering mainstream orthopedic care, this consensus will help streamline clinical decision-making, improve patient outcomes, and ensure consistency in practice across diverse healthcare settings in the country.
The committee behind this movement includes a robust team of experienced professionals: Dr. L. Tomar, Dr. Ashim Gupta, Dr. Samarth Mittal, Dr. Jujhar Singh, Dr. Ravi Chauhan, Dr. SS Amarnath, Dr. Bishno Patro, Dr. Krishna Poddar, Dr. GK Kumar, Dr. Madhan Jeyaraman, Dr. Tushar, among others. Their collective expertise and commitment promise a strong foundation for this critical national effort.
A Bigger and Bolder Third Edition
With two successful editions now behind them, the organizers have already begun planning for the 3rd Delhi Orthobiologics Course. The vision is clear—to make the next edition not only larger and more impactful but to position it as a globally recognized academic event in the realm of regenerative orthopedic medicine.
The focus will remain on driving high-quality education, bridging the gap between innovation and practice, and fostering a global dialogue around the potential of biologic solutions in orthopedics.
Delhi: A New Epicenter for Regenerative Medicine
As regenerative medicine evolves rapidly across the globe, Delhi is positioning itself not merely as a participant in this transformation—but as a leader. The Delhi Orthobiologics Course is more than a conference; it is a movement. A movement that champions science, collaboration, and patient-centered care in one of the most exciting frontiers of modern medicine.
In the words of many who attended: Orthobiologics is not just the future—it is the now. And Delhi is leading the way.
